In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors

The improvement of cancer chemotherapy remains a major challenge, and thus new drugs are urgently required to develop new treatment regimes. Curcumin, a polyphenolic antioxidant derived from the rhizome of turmeric (Curcuma longa L.), has undergone extensive preclinical investigations and, thereby,...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Mohamed E. M., Yücer, Rümeysa, Dawood, Mona, Hegazy, Mohamed-Elamir F., Drif, Assia, Ooko, Edna, Kadioglu, Onat, Seo, Ean-Jeong, Kamounah, Fadhil S., Titinchi, Salam J., Bachmeier, Beatrice, Efferth, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000198/
https://www.ncbi.nlm.nih.gov/pubmed/35409325
http://dx.doi.org/10.3390/ijms23073966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000198/
https://www.ncbi.nlm.nih.gov/pubmed/35409325
http://dx.doi.org/10.3390/ijms23073966

Ejemplares similares